149 related articles for article (PubMed ID: 36279827)
1. Salivary metabolomics of burning mouth syndrome: A cross-sectional study.
Ye L; Dai Q; Hou F; Wu C; Qiu X; Yuan P; Chen F; Meng Y; Feng X; Jiang L
Arch Oral Biol; 2022 Dec; 144():105552. PubMed ID: 36279827
[TBL] [Abstract][Full Text] [Related]
2. Opiorphin in burning mouth syndrome patients: a case-control study.
Salarić I; Sabalić M; Alajbeg I
Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
[TBL] [Abstract][Full Text] [Related]
3. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines.
Pekiner FN; Gümrü B; Demirel GY; Ozbayrak S
J Oral Pathol Med; 2009 Mar; 38(3):269-75. PubMed ID: 19141055
[TBL] [Abstract][Full Text] [Related]
4. Mineral and trace element analysis of saliva from patients with BMS: a cross-sectional prospective controlled clinical study.
López-Jornet P; Juan H; Alvaro PF
J Oral Pathol Med; 2014 Feb; 43(2):111-6. PubMed ID: 23869755
[TBL] [Abstract][Full Text] [Related]
5. Altered Caffeine Metabolism Is Associated With Recurrent Hypoglycemia in Type 2 Diabetes Mellitus: A UPLC-MS-Based Untargeted Metabolomics Study.
Lijing W; Sujie K; Linxi W; Lishan H; Liqin Q; Zhidong Z; Kejun W; Mengjun Z; Xiaoying L; Xiaohong L; Libin L
Front Endocrinol (Lausanne); 2022; 13():843556. PubMed ID: 35784552
[TBL] [Abstract][Full Text] [Related]
6. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of metabolite differences in skin between Clapp's Favorite and its mutant Red Clapp's Favorite through non-targeted metabolomics].
Mu H; Ci Z; Aisajan M; Liang Y; Liu X; DU X; Yu Q; Li Q; Li Y
Se Pu; 2021 Nov; 39(11):1203-1212. PubMed ID: 34677015
[TBL] [Abstract][Full Text] [Related]
8. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile.
de Moura SA; de Sousa JM; Lima DF; Negreiros AN; Silva Fde V; da Costa LJ
Gerodontology; 2007 Sep; 24(3):173-6. PubMed ID: 17696895
[TBL] [Abstract][Full Text] [Related]
9. Salivary metabolome indicates a shift in tyrosine metabolism in patients with burning mouth syndrome: a prospective case-control study.
Moreau C; El Habnouni C; Lecron JC; Morel F; Delwail A; Le Gall-Ianotto C; Le Garrec R; Misery L; Piver E; Vaillant L; Lefevre A; Emond P; Blasco H; Samimi M
Pain; 2023 Mar; 164(3):e144-e156. PubMed ID: 35916738
[TBL] [Abstract][Full Text] [Related]
10. Burning mouth syndrome: a therapeutic approach involving mechanical salivary stimulation.
de Souza FT; Amaral TM; dos Santos TP; Abdo EN; Aguiar MC; Teixeira AL; Kummer AM; Abreu MH; Silva TA
Headache; 2012 Jun; 52(6):1026-34. PubMed ID: 22084903
[TBL] [Abstract][Full Text] [Related]
11. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
Suh KI; Kim YK; Kho HS
Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome.
Tvarijonaviciute A; Aznar-Cayuela C; Rubio CP; Ceron JJ; López-Jornet P
J Oral Pathol Med; 2017 May; 46(5):387-392. PubMed ID: 27862315
[TBL] [Abstract][Full Text] [Related]
13. Reduction in unstimulated salivary flow rate in burning mouth syndrome.
Poon R; Su N; Ching V; Darling M; Grushka M
Br Dent J; 2014 Oct; 217(7):E14. PubMed ID: 25303607
[TBL] [Abstract][Full Text] [Related]
14. Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome.
Kang JH; Kim YY; Chang JY; Kho HS
Arch Oral Biol; 2017 Jun; 78():58-64. PubMed ID: 28199919
[TBL] [Abstract][Full Text] [Related]
15. Characteristic changes of saliva and taste in burning mouth syndrome patients.
Imura H; Shimada M; Yamazaki Y; Sugimoto K
J Oral Pathol Med; 2016 Mar; 45(3):231-6. PubMed ID: 26293497
[TBL] [Abstract][Full Text] [Related]
16. Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome.
Simcić D; Pezelj-Ribarić S; Grzić R; Horvat J; Brumini G; Muhvić-Urek M
Mediators Inflamm; 2006; 2006(1):54632. PubMed ID: 16864905
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic analysis of the sera of patients with the long-term inhalation of caffeine-sodium benzoate using LC-MS.
Yu T; Yan Q; Tian L; Zhao H; Suo F; Suriguga ; Li W; Guo R; Yang H
Biomed Chromatogr; 2023 May; 37(5):e5567. PubMed ID: 36515669
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of the acid-soluble fraction of whole and major gland saliva in burning mouth syndrome patients.
Cabras T; Manconi B; Castagnola M; Sanna MT; Arba M; Acharya S; Ekström J; Carlén A; Messana I
Arch Oral Biol; 2019 Feb; 98():148-155. PubMed ID: 30496935
[TBL] [Abstract][Full Text] [Related]
19. Salivary biomarkers in burning mouth syndrome: A systematic review and meta-analysis.
Fernández-Agra M; González-Serrano J; de Pedro M; Virto L; Caponio VCA; Ibáñez-Prieto E; Hernández G; López-Pintor RM
Oral Dis; 2023 Oct; 29(7):2600-2613. PubMed ID: 36135356
[TBL] [Abstract][Full Text] [Related]
20. Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics.
Ji EH; Diep C; Liu T; Li H; Merrill R; Messadi D; Hu S
Mol Pain; 2017 Jan; 13():1744806916686796. PubMed ID: 28326926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
